Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michał Danecki
Observed names:
M. Danecki,
Michal Danecki
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0009-0007-3056-7349
Observed ORCID:
0009-0007-3056-7349
OpenAlex ID:
A5001583669
Outcomes of Therapies Following Discontinuation of Non-Covalent Bruton's Tyrosine Kinase Inhibitors for Patients with Chronic Lymphocytic Leukemia and Richter Transformation: Results from an International, Multicenter Study
2024
·
Meghan C. Thompson
, Seema A. Bhat
, et al.
·
Blood
·
7
PDF
Richter transformation – retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group
2023
·
Oktawia Sośnia
, Katarzyna Pruszczyk
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
6
Bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma.
2024
·
Michał Danecki
, Wojciech Jurczak
·
Acta Haematologica Polonica
·
3
PDF
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia – real-world analysis of Polish adult leukemia study group
2026
·
Anita Soboń
, Elżbieta Iskierka-Jażdżewska
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
P1221: Diffuse Large B-cell Lymphoma Richter Syndrome in Chronic Lymphocytic Leukemia – a Retrospective Analysis of Treatment Outcomes in Polish Adult Leukemia Study Group
2022
·
O. Sośnia
, M. Danecki
, et al.
·
HemaSphere
Show more works
View as search
Works count:
5
Citation count:
16
H-index:
3
I10-index:
Year
Topic
Type